Product Information

HYDROXYZINE HCL 25 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.0324 per EA under NDC 00093506101. Its NADAC has been published 677 times since Nov 28, 2013.

FDA first approved this application on Jan 10, 1986. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

HYDROXYZINE HCL 25 MG TABLET

Hydroxyzine Hydrochloride
$0.0324per EA

Strength

25 mg/1

NDC

00093506101

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

HYDROXYZINE DIHYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA088618

FDA Approved

1/10/1986

TE Code

AB

On Market Since

10/9/2012

Pharmacological Classes

Antihistamine
Histamine Receptor Antagonists

Price Statistics

The NADAC for HYDROXYZINE HCL 25 MG TABLET has been published 677 times since Nov 28, 2013, and over the history we have for it it has declined 64.3%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0324 per EA
All-time high$0.1062 (Apr 15, 2015)
All-time low$0.0324 (Oct 21, 2026)
52-week high$0.0356
52-week low$0.0324
Median price$0.0601
Average price$0.0632
Largest weekly change+60.2% (Jan 19, 2022)
Weeks tracked677
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-0.4%

3M

-7.4%

6M

-6.2%

1Y

-9.0%

3Y

-21.5%

5Y

-39.6%

All

-64.3%

Generic Alternatives

The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of HYDROXYZINE HCL 25 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for HYDROXYZINE HCL 25 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.0324 per EA (NDC 00093506101), effective Nov 11, 2026.

How has the price of HYDROXYZINE HCL 25 MG TABLET changed over time?

Over the history we have for it, the NADAC for HYDROXYZINE HCL 25 MG TABLET has declined 64.3%. It has been tracked across 677 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for HYDROXYZINE HCL 25 MG TABLET?

Since Nov 28, 2013, the NADAC for HYDROXYZINE HCL 25 MG TABLET has ranged from a low of $0.0324 (Oct 21, 2026) to a high of $0.1062 (Apr 15, 2015), with a median of $0.0601 per EA.

Are there cheaper alternatives to HYDROXYZINE HCL 25 MG TABLET?

7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HYDROXYZINE HCL 25 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures HYDROXYZINE HCL 25 MG TABLET?

HYDROXYZINE HCL 25 MG TABLET (NDC 00093506101) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.